{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:38Z","timestamp":1787013938219,"version":"build-2736575974"},"reference-count":125,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The epidemiology, outcome and targeted immunotherapy in adolescent and young adult non\u2010Hodgkin and Hodgkin lymphoma were discussed during the\n                    <jats:italic>6th International Symposium on Childhood, Adolescent and Young Adult Non\u2010Hodgkin Lymphoma<\/jats:italic>\n                    September 26th\u201329th 2018 in Rotterdam, the Netherlands. This review summarizes some of those presentations, as well as other current and novel antibody therapy, immune check\u2010point inhibitors, chimeric antigen receptor T\u00a0cells, cancer vaccines and cytotoxic T lymphocyte therapy.\n                  <\/jats:p>","DOI":"10.1111\/bjh.15789","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T21:40:49Z","timestamp":1549489249000},"page":"1142-1157","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non\u2010Hodgkin and Hodgkin\u00a0lymphoma"],"prefix":"10.1111","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-4611","authenticated-orcid":false,"given":"Monika L.","family":"Metzger","sequence":"first","affiliation":[{"name":"Department of Oncology St Jude Children's Research Hospital Memphis TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mauz\u2010K\u00f6rholz","sequence":"additional","affiliation":[{"name":"P\u00e4diatrische H\u00e4matologie und Onkologie Justus\u2010Liebig\u2010Universit\u00e4t Gie\u00dfen and Medical Faculty of the Martin\u2010Luther University of Halle Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"e_1_2_13_2_1","first-page":"581","article-title":"High durable CR rates in Relapsed\/Refractory (R\/R) aggressive B\u2010NHL treated with the CD19\u2010directed CAR T cell product JCAR017 (TRANSCEND NHL 001): defined composition allows for dose\u2010finding and definition of pivotal cohort","volume":"130","author":"Abramson J.S.","year":"2017","journal-title":"Blood"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2069"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"e_1_2_13_6_1","first-page":"67","article-title":"Blinatumomab significantly enhanced cytotoxicity and T\u2010cell cytokine secretion against Burkitt lymphoma (BL) and primary mediastinal B\u2010cell lymphoma (PMBL)","volume":"182","author":"Awashti A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/13928"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25072"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20684"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22102"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.565"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040890"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5304"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.3179"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036665"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.3369"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15491"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(03)70003-1"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30426-1"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60313-X"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3154"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-778480"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214561"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.2655"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-766121"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26681"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.11.005"},{"key":"e_1_2_13_28_1","first-page":"14","article-title":"Epidemiology and outcome of adolescents andyoung adults with NHL and Hodgkinlymphoma","volume":"182","author":"Flower A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt378"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.167"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1586"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.255"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13040"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx028"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.021"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0698"},{"key":"e_1_2_13_38_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2018-99-111279","article-title":"Response\u2010adapted therapy with Nivolumab and Brentuximab Vedotin (BV), followed by BV and Bendamustine for suboptimal response, in children, adolescents, and young adults with standard\u2010risk Relapsed\/Refractory classical Hodgkin lymphoma","volume":"132","author":"Harker\u2010Murray P.D.","year":"2018","journal-title":"Blood"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30979"},{"key":"e_1_2_13_41_1","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood.V128.22.4194.4194","article-title":"Polatuzumab vedotin combined with Bendamustine (B) and Rituximab (R) or Obinutuzumab (G) in patients with Relapsed or Refractory (R\/R) Follicular Lymphoma (FL) or Diffuse Large B\u2010Cell Lymphoma (DLBCL): preliminary results of a Phase Ib\/II Dose\u2010Escalation Study","volume":"128","author":"Herrera A.F.","year":"2016","journal-title":"Blood"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"e_1_2_13_43_1","first-page":"59","article-title":"Brentuximab vedotin and rituximab with reduced toxicity chemotherapy in children, adolescents and Young Adults with newly diagnosed Hodgkin lymphoma","volume":"182","author":"Hochberg J.C.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563627"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13388"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.09.001"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.07.009"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-018-0103-z"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_199505"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1032966"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29869"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0696-7"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3024"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-815183"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24267"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-331421"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"e_1_2_13_58_1","first-page":"37","article-title":"Novel pathways of oncogenesis in anaplastic large cell lymphoma (ALCL)","volume":"182","author":"Lim M.S.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30153-4"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2098"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0080"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000035"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1559664"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000547939.70565.bf"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386763"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.6791"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-418640"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000547935.17200.58"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203043060906"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5827"},{"key":"e_1_2_13_72_1","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1200\/JCO.2016.34.15_suppl.10507","article-title":"Results of the randomized Intergroup trial Inter\u2010B\u2010NHL Ritux 2010 for children and adolescents with high\u2010risk B\u2010cell non\u2010Hodgkin lymphoma (B\u2010NHL) and mature acute leukemia (B\u2010AL): evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen","volume":"34","author":"Minard\u2010Colin V.","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.8519"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70095-0"},{"key":"e_1_2_13_76_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V126.23.175.175","article-title":"Prediction of primary treatment outcome using gene expression profiling of pre\u2010treatment biopsies obtained from childhood and adolescent Hodgkin lymphoma patients (abstract)","volume":"126","author":"Mottok A.","year":"2015","journal-title":"Blood"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.07.013"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-063594"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1974"},{"key":"e_1_2_13_82_1","first-page":"149","article-title":"Adoptive cell therapy with donor lymphocytes for EBV\u2010associated lymphomas developing after allogeneic marrow transplants","author":"O'Reilly R.J.","year":"1996","journal-title":"Important Advances in Oncology"},{"key":"e_1_2_13_83_1","first-page":"4342","article-title":"Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor","volume":"58","author":"Orlowski R.Z.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.73"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84813"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201000"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0034"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94306"},{"key":"e_1_2_13_90_1","first-page":"29","article-title":"Early response data for pediatric patients with Non\u2010Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T\u2010cells","volume":"182","author":"Rivers J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.5.1549"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-017-0383-0"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-785840"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.177"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802561"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13242"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_2_13_98_1","first-page":"577","article-title":"Primary analysis of Juliet: a global, pivotal, phase 2 trial of CTL019 in adult patients with relapsed or refractory diffuse large B\u2010cell lymphoma","volume":"130","author":"Schuster S.J.","year":"2017","journal-title":"Blood"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-577189"},{"key":"e_1_2_13_100_1","first-page":"431","article-title":"A phase I\/II study of Crizotinib for recurrent or refractory anaplastic lymphoma Kinase\u2010positive anaplastic large cell lymphoma and a phase I study of Crizotinib for recurrent or refractory neuroblastoma : study protocol for a Multicenter Single\u2010arm Open\u2010label Trial","volume":"72","author":"Sekimizu M.","year":"2018","journal-title":"Acta Medica Okayama"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-439570"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-814913"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1517"},{"key":"e_1_2_13_104_1","first-page":"5845","article-title":"Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B\u2010cell lymphoma","volume":"62","author":"Timmerman J.M.","year":"2002","journal-title":"Cancer Research"},{"key":"e_1_2_13_105_1","first-page":"38","article-title":"Origins and pathogenesis of ALCL","volume":"182","author":"Turner S.D.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf8621"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.180554"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-741058"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651380"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-1-36"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2920"},{"key":"e_1_2_13_112_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1365"},{"key":"e_1_2_13_113_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.003"},{"key":"e_1_2_13_114_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.1391"},{"key":"e_1_2_13_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3884"},{"key":"e_1_2_13_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.226"},{"key":"e_1_2_13_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0973"},{"key":"e_1_2_13_118_1","first-page":"16","article-title":"Nonbiological factors affecting outcomes in adolescent and young adults with lymphoma","volume":"182","author":"Xavier A.C.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_119_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.910170"},{"key":"e_1_2_13_120_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"e_1_2_13_121_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"e_1_2_13_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70501-1"},{"key":"e_1_2_13_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00584-7"},{"key":"e_1_2_13_124_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819042000209404"},{"key":"e_1_2_13_125_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0494"},{"key":"e_1_2_13_126_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-758383"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15789","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15789","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15789","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T17:25:32Z","timestamp":1694366732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/bjh.15789"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15789","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"2019-02-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}